FDA Brief

Warning letters Drugs

FDA warning letter to

RoyceDerm LLC

High riskIssued Oct 1Posted Oct 6Center for Drug Evaluation and Research (CDER)

FDA says RoyceDerm LLC marketed Herpes Relief Cream, an unapproved new drug, for herpes symptoms on its website.

What happened

FDA reviewed RoyceDerm's website https://roycederm.com/ in July 2026. It found the product "Herpes Relief Cream" labeled to relieve herpes symptoms, rashes or blisters, redness, and pain, with before-and-after images. FDA concluded the product is an unapproved new drug because no approved application is in effect for it.

What FDA found

  1. Herpes Relief Cream is a drug because its labeling says it is intended to treat herpes symptoms.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)
  2. It is a new drug because it is not generally recognized as safe and effective for its labeled use.

    FD&C Act section 201(p), 21 U.S.C. 321(p)
  3. No FDA-approved application is in effect, so selling it violates the unapproved new drug rules.

    FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)

What FDA wants

FDA asks RoyceDerm to send a written response to FDAAdvisory@fda.hhs.gov within 15 business days. The response should include corrective steps, steps to prevent recurrence, related documents, and reference number 734781.

Who should pay attention

  • online sellers of health products
  • companies marketing herpes or STI creams
  • regulatory staff reviewing website claims for OTC drugs

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk